Cargando…

Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series

Pericardial diseases secondary to immune checkpoint inhibitors (ICI) are rare. Here, we describe two cases of immune-related pericarditis caused by ICI for treatment of advanced NSCLC. Select patients can be successfully rechallenged with ICI after immune-related pericardial disease.

Detalles Bibliográficos
Autores principales: Chye, Adrian M., Nordman, Ina I. C., Sverdlov, Aaron L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395697/
https://www.ncbi.nlm.nih.gov/pubmed/36017099
http://dx.doi.org/10.3389/fcvm.2022.964324
_version_ 1784771759906488320
author Chye, Adrian M.
Nordman, Ina I. C.
Sverdlov, Aaron L.
author_facet Chye, Adrian M.
Nordman, Ina I. C.
Sverdlov, Aaron L.
author_sort Chye, Adrian M.
collection PubMed
description Pericardial diseases secondary to immune checkpoint inhibitors (ICI) are rare. Here, we describe two cases of immune-related pericarditis caused by ICI for treatment of advanced NSCLC. Select patients can be successfully rechallenged with ICI after immune-related pericardial disease.
format Online
Article
Text
id pubmed-9395697
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93956972022-08-24 Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series Chye, Adrian M. Nordman, Ina I. C. Sverdlov, Aaron L. Front Cardiovasc Med Cardiovascular Medicine Pericardial diseases secondary to immune checkpoint inhibitors (ICI) are rare. Here, we describe two cases of immune-related pericarditis caused by ICI for treatment of advanced NSCLC. Select patients can be successfully rechallenged with ICI after immune-related pericardial disease. Frontiers Media S.A. 2022-08-09 /pmc/articles/PMC9395697/ /pubmed/36017099 http://dx.doi.org/10.3389/fcvm.2022.964324 Text en Copyright © 2022 Chye, Nordman and Sverdlov. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Chye, Adrian M.
Nordman, Ina I. C.
Sverdlov, Aaron L.
Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series
title Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series
title_full Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series
title_fullStr Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series
title_full_unstemmed Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series
title_short Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series
title_sort successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: clinical case series
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395697/
https://www.ncbi.nlm.nih.gov/pubmed/36017099
http://dx.doi.org/10.3389/fcvm.2022.964324
work_keys_str_mv AT chyeadrianm successfulimmunecheckpointinhibitorrechallengeafterimmunerelatedpericarditisclinicalcaseseries
AT nordmaninaic successfulimmunecheckpointinhibitorrechallengeafterimmunerelatedpericarditisclinicalcaseseries
AT sverdlovaaronl successfulimmunecheckpointinhibitorrechallengeafterimmunerelatedpericarditisclinicalcaseseries